EPCAM and pancreatic adenocarcinoma: Initial functional validation was performed using a Jurkat dual-reporter cell line J–N/N, where we quantified CAR surface expression levels and antigen-specific signaling activation in response to EpCAM positive pancreatic adenocarcinoma cell lines.